Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Nivolumab"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Tagliamento%2C+Marco%22&type=Person&filter%5B%5D=topic_facet%3A%22Nivolumab%22
/vufind/Search/Results?lookfor=%22Tagliamento%2C+Marco%22&type=Person&filter%5B%5D=topic_facet%3A%22Nivolumab%22
Search /vufind/Search2/Results?lookfor=%22Tagliamento%2C+Marco%22&type=Person&filter%5B%5D=topic_facet%3A%22Nivolumab%22
PubPharm (12)
1
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma
enthalten in:
Critical reviews in oncology/hematology
| 2022
von
Tagliamento, M.
|
Bironzo, P.
|
Curcio, H.
| +18
Wird geladen...
2
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLC
enthalten in:
European journal of clinical investigation
| 2022
von
Carbone, F.
|
Ministrini, S.
|
Bonaventura, A.
| +17
Wird geladen...
3
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer
enthalten in:
Frontiers in immunology
| 2020
von
Ottonello, S.
|
Genova, C.
|
Cossu, I.
| +16
Wird geladen...
4
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
enthalten in:
Clinical & experimental metastasis
| 2019
von
Carbone, F.
|
Grossi, F.
|
Bonaventura, A.
| +17
Wird geladen...
5
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC : a pilot study
enthalten in:
Cancer immunology, immunotherapy : CII
| 2019
von
Bonaventura, A.
|
Grossi, F.
|
Carbone, F.
| +17
Wird geladen...
6
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
enthalten in:
Clinical & experimental metastasis
| 2019
von
Carbone, F.
|
Grossi, F.
|
Bonaventura, A.
| +17
Wird geladen...
7
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
enthalten in:
Clinical & experimental metastasis
| 2019
von
Carbone, F.
|
Grossi, F.
|
Bonaventura, A.
| +17
Wird geladen...
8
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
enthalten in:
Clinical & experimental metastasis
| 2019
von
Carbone, F.
|
Grossi, F.
|
Bonaventura, A.
| +17
Wird geladen...
9
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus
enthalten in:
Immunotherapy
| 2019
von
Tagliamento, M.
|
Grossi, F.
|
Paolino, S.
| +5
Wird geladen...
10
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study
enthalten in:
Cancer immunology immunotherapy
| 2019
von
Bonaventura, A.
|
Grossi, F.
|
Carbone, F.
| +17
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Nivolumab
Medienart
12
Aufsätze
10
E-Artikel
10
E-Ressourcen
2
Gedruckte Aufsätze
Zeitschriftentitel
4
Clinical & experimental metastasis
3
Cancer immunology immunotherapy
1
Cancer immunology, immunotherapy : CII
1
Critical reviews in oncology/hematology
1
European journal of clinical investigation
1
Frontiers in immunology
1
Immunotherapy
Alle anzeigen ...
weniger ...
Thema
Nivolumab
6
Journal Article
5
31YO63LBSN
4
Immunotherapy
4
Inflammation
4
Lung cancer
4
NSCLC
4
Neutrophil
4
Non-small cell lung cancer
4
Osteopontin
4
Overall survival
4
PCSK9
3
Antineoplastic Agents, Immunological
3
Biomarkers, Tumor
3
nivolumab
2
Research Support, Non-U.S. Gov't
2
non-small cell lung cancer
1
106441-73-0
1
9007-41-4
1
Antineoplastic Agents
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2020-
9
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...
